MONOVISC
- Primary DI
- 08437027710018
- Brand
- MONOVISC
- Company
- SAIMA GLOBAL FARMA S.L.
- Model
- 277515
- Device description
- MONOVISC is a viscoelastic solution of high-molecular weight hyaluronan. Hyaluronan acts as a lubricant and shock absorber in the joint. MONOVISC is used to relieve knee pain due to osteoarthritis in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen.
- Published
- 2024-11-13
- Public version status
- New
- Distribution status
- In Commercial Distribution
- MRI safety
- Labeling does not contain MRI Safety Information
- Rx
- true
- Sterile
- true
- Single use
- true
Product Codes#
| Code | Name |
|---|---|
| MOZ | Acid, Hyaluronic, Intraarticular |
Product Code Classifications#
| Code | Device | Specialty | Class |
|---|---|---|---|
| MOZ | Acid, Hyaluronic, Intraarticular | Unknown | 3 |
Premarket Submissions#
| Submission | Supplement |
|---|---|
| P090031 | 000 |
Premarket Details#
Identifiers And Packaging#
| Identifier | Type | Agency | Package quantity | Status |
|---|---|---|---|---|
| 08437027710018 | Primary | GS1 | 0 |
Alternate GTIN / UPC / EAN Codes
| Source identifier | GTIN-14 normalized | EAN-13 |
|---|---|---|
| 08437027710018 | 08437027710018 | 8437027710018 |
GMDN Terms#
| Term | Definition |
|---|---|
| Synovial fluid supplementation medium | A sterile viscous/elastic solution or gel (e.g., comprised of hyaluronic acids and their polymeric derivatives) intended to be injected into joints (particularly large, load-bearing joints such as the hip or knee) to help cushion the joint, especially in cases of endogenous synovial fluid reduced viscosity from degenerative disease. |
Storage And Handling#
| Type | Low | High | Condition |
|---|---|---|---|
| Storage Environment Temperature | 2 Degrees Celsius | 25 Degrees Celsius |
Sterilization Methods#
| Method |
|---|
Regulatory Flags#
- DUNS number
- 468910220
- Device count
- 1
- Lot or batch
- true
- Expiration date on label
- true
Other Devices From This Company#
| Primary DI | Brand | Model | Catalog | Published |
|---|---|---|---|---|
| 08437027710117 | SCULPTRA | 2 Vials | 2026-02-19 | |
| 08437027710100 | SCULPTRA | 2 Vials | 2026-02-19 | |
| 08437027710063 | RESTYLANE DEFYNE | Gel 1 mL Syringe | 2025-06-30 | |
| 08437027710070 | RESTYLANE KYSSE | Gel 1 mL Syringe | 2025-06-30 | |
| 08437027710087 | RESTYLANE LYFT WITH LIDOCAINE | Gel 1 mL Syringe | 2025-06-30 | |
| 08437027710094 | RESTYLANE REFYNE | Gel 1 mL Syringe | 2025-06-30 | |
| 08437027710001 | DUROLANE | 1082020 | 2024-11-13 | |
| 08437027710025 | ORTHOVISC | 277500 | 2024-11-13 | |
| 08437027710049 | SYNVISC ONE | 58468-0090-3 | 2024-11-13 | |
| 08437027710056 | SYNVISC | 58468-0090-1 | 2024-11-13 |
Other Devices Sharing Product Codes#
| Primary DI | Brand | Company | Product code | Published |
|---|---|---|---|---|
| 05065026658012 | Euflexxa | MAPLESTONE DEVELOPMENTS LIMITED | MOZ | 2026-03-04 |
| 05065026658050 | Synvisc | MAPLESTONE DEVELOPMENTS LIMITED | MOZ | 2026-03-04 |
| 05065026658005 | Durolane | MAPLESTONE DEVELOPMENTS LIMITED | MOZ | 2026-03-04 |
| 05065026658067 | Euflexxa | MAPLESTONE DEVELOPMENTS LIMITED | MOZ | 2026-03-04 |
| 05065026658029 | Monovisc | MAPLESTONE DEVELOPMENTS LIMITED | MOZ | 2026-03-04 |
| 05065026658036 | Orthovisc | MAPLESTONE DEVELOPMENTS LIMITED | MOZ | 2026-03-04 |
| 05065026658043 | Synvisc | MAPLESTONE DEVELOPMENTS LIMITED | MOZ | 2026-03-04 |
| 05065026658074 | Synvisc | MAPLESTONE DEVELOPMENTS LIMITED | MOZ | 2026-03-04 |
| 08052570475131 | Supartz | DAMBO SRL | MOZ | 2025-11-26 |
| M713891220750010 | HYMOVIS® ONE 32mg/4ml syringe | FIDIA FARMACEUTICI SPA | MOZ | 2025-11-07 |
| M713FID075010 | HYMOVIS® ONE Professional Sample, 32mg/4ml syringe | FIDIA FARMACEUTICI SPA | MOZ | 2025-11-07 |
| 08052570473441 | Euflexxa | DAMBO SRL | MOZ | 2025-09-25 |
| 08052570473212 | Durolane | DAMBO SRL | MOZ | 2025-09-25 |
| 08052570473229 | Monovisc | DAMBO SRL | MOZ | 2025-09-25 |
| 08052570477654 | Euflexxa | DAMBO SRL | MOZ | 2025-09-25 |
| 03770034301165 | Synvisc | UNIVERDERM | MOZ | 2025-03-13 |
| 03770034301158 | Synvisc | UNIVERDERM | MOZ | 2025-03-13 |
| 03770034301172 | Synvisc | UNIVERDERM | MOZ | 2025-03-13 |
| 08437027710001 | DUROLANE | SAIMA GLOBAL FARMA S.L. | MOZ | 2024-11-13 |
| 08437027710025 | ORTHOVISC | SAIMA GLOBAL FARMA S.L. | MOZ | 2024-11-13 |
| 08437027710049 | SYNVISC ONE | SAIMA GLOBAL FARMA S.L. | MOZ | 2024-11-13 |
| 08437027710056 | SYNVISC | SAIMA GLOBAL FARMA S.L. | MOZ | 2024-11-13 |
| M713891220879010 | TRILURON | FIDIA FARMACEUTICI SPA | MOZ | 2024-05-07 |
| 00193493000753 | GenVisc 850 Sodium Hyaluronate | Avanos Medical, Inc. | MOZ | 2024-03-06 |
| 00193493000760 | TriVisc Sodium Hyaluronate | Avanos Medical, Inc. | MOZ | 2024-03-06 |
| 10193493000750 | GenVisc 850 Sodium Hyaluronate | Avanos Medical, Inc. | MOZ | 2024-03-06 |
| 10193493000767 | TriVisc Sodium Hyaluronate | Avanos Medical, Inc. | MOZ | 2024-03-06 |
| M713891220724200 | Hyalgan® Sodium Hylauronate Pre-filled Syringe - 2mL | FIDIA FARMACEUTICI SPA | MOZ | 2023-10-16 |
| 10389130444418 | SUPARTZ FX sodium hyaluronate | BIOVENTUS LLC | MOZ | 2023-09-28 |
| M713891220724120 | Hyalgan® Sodium Hyaluronate 2mL Vial | FIDIA FARMACEUTICI SPA | MOZ | 2023-09-13 |